Piper Sandler maintains overweight on Inspire Medical stock
Piper Sandler reaffirmed its positive stance on Inspire Medical Systems (NYSE:NYSE:INSP), maintaining an Overweight rating with a $260.00 price target. The endorsement comes after a steep 14.15% ...
Future Market Insights2d
Sleep Apnea Implants Industry to Reach USD 1,158.1 Million by 2033 at a 13.8% of CAGR
The global sleep apnea implants market is expected to grow from USD 317.1 million in 2023 to USD 1,158.1 million by 2033, at ...
RBC Capital Sticks to Their Buy Rating for Inspire Medical Systems (INSP)
RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Inspire Medical Systems (INSP – Research Report) yesterday and set a price ...
Inspire Medical Systems: Strong Q4 Sales Beat Expectations Amid Competitive and Organizational Uncertainties
Wells Fargo analyst Larry Biegelsen maintained a Hold rating on Inspire Medical Systems (INSP – Research Report) yesterday and set a price ...